BGDE earnings analysis
What we found in BGDE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q excerpt does not include the financial statements or MD&A needed to assess revenue, margins, EPS, segment performance, balance-sheet trends, or cash flow versus the prior quarter or prior year. Positive disclosures include effective controls and Nasdaq compliance regained on June 16, 2026, but that compliance is conditional on maintaining at least $5 million of stockholders’ equity each quarter for twelve months. The most material risks are potential Nasdaq delisting, substantial dilution from the Series D financing and warrant, and unresolved obligations with balances of $11.3 million, $14.1 million, and $1.9 million.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Effective disclosure controls
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026. The filing also states that there were no changes during the three-month period ended June 30, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
- Nasdaq compliance regained
- The company received Nasdaq confirmation on June 16, 2026 that it had regained compliance with Nasdaq Listing Rules, subject to maintaining stockholders’ equity of at least $5 million in each quarter for a twelve-month period beginning with the quarter ended June 30, 2026.
- New financing completed
- The company issued 16,700 shares of Series D Convertible Preferred Stock and a five-year warrant for 926,748 common shares on June 30, 2026, providing a new financing source despite associated dilution and covenant constraints.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Conditional Nasdaq compliance
- Nasdaq compliance remains conditional on maintaining stockholders’ equity of at least $5 million in each quarter for a twelve-month period beginning with the quarter ended June 30, 2026. Failure to comply could result in delisting, reduced capital-markets access, and pressure on the stock price.
- Variable-price equity dilution
- The Series D Preferred Stock converts at 95% of the lowest daily VWAP over the preceding five trading days, subject to a $1.80 floor, while dividends accrue at 5% annually and can rise to 18% upon triggering events. The related warrant covers 926,748 common shares at an exercise price of $10.81 per share, creating substantial potential dilution.
- Defaulted and disputed obligations
- Several obligations are described as being in default or otherwise unresolved: the Celsius Promissory Note had an outstanding balance of $11.3 million, the Marshall Loan had an outstanding balance of $14.1 million, and $1.9 million was drawn under the W Capital Loan, which expired in March 2023.
What they said about what is next.
No quantitative revenue, EPS, margin, or cash-flow guidance was provided in the supplied 10-Q text. The filing states that Nasdaq compliance must be maintained with stockholders’ equity of at least $5 million in each quarter for a twelve-month period beginning with the quarter ended June 30, 2026.
The filing reads about the same as the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing BGDE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever